UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Trump names former Florida AG Pam Bondi as his new pick for U.S. attorney general
After former Rep. Matt Gaetz withdrew from consideration, President-elect Donald Trump named Pam Bondi, a former attorney general of Florida, as his next pick for U.S. attorney general.
Police report gives details, timeline of the sexual assault claim against Pete Hegseth
The woman who accused then-Fox News host of sexual assault in 2017 said that she "remembered saying 'no' a lot," according to a police report. Hegseth is President-elect Donald Trump's choice for Secretary of Defense.
Alabama Black Belt’s sewer crisis a tougher fix for residents in manufactured homes
Poor sanitation has long plagued residents in Alabama’s Black Belt. For people with manufactured houses, finding a solution has been more challenging.
In Birmingham, Black men’s groups work to save young men from the cycle of gun violence
As the city inches closer to its homicide record, community members are trying to address a sense of fatalism and lack of opportunity felt by some young men.
What is the ICC and can it really arrest Israeli Prime Minister Benjamin Netanyahu?
The ICC also issued warrants for Yoav Gallant, former Israeli defense minister, and Hamas leader Muhammad Deif. But it doesn't have an enforcement mechanism and relies on states to make the arrests.
Former Brazilian president indicted over alleged coup plot
Brazil's former President Jair Bolsonaro and several others have been charged with attempting to overthrow incoming government of President Luiz Inácio Lula da Silva in 2022.
